GleamWall
中文EN

VMD VIEMED HEALTHCARE, INC.

Services-Misc Health & Allied Services, NEC · Nasdaq · SEC CIK 1729149 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY21.8%
TTM net income YoY14.8%
TTM EPS YoY11.8%
Revenue 3-yr CAGR22.3%
Net income 3-yr CAGR19.3%

Margins

Gross margin57.4%
Operating margin7.8%
Net margin5.0%
FCF margin6.9%
EBITDA margin12.9%

Returns

ROE11.0%
ROA7.6%
ROIC (approx.)11.8%
Asset turnover1.51x

Leverage & solvency

Liabilities / assets26.8%
Debt / equity0.03x
Current ratio1.25x
Interest coverage—

Cash quality & payout

Operating cash flow / net income3.45x
Accruals ratio-18.7%
Payout ratio—
Capex / revenue10.5%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue$80.67M$78.10M$75.41M$76.18M$71.91M$63.06M$59.13M$60.70M
Cost of revenue$34.48M$33.05M$32.59M$32.08M$30.57M$26.32M$25.85M$24.56M
Gross profit$46.19M$45.05M$42.83M$44.10M$41.34M$36.73M$33.28M$36.14M
R&D expense$501,000$504,000$579,000$598,000$775,000$847,000$797,000$803,000
SG&A expense$35.51M$37.13M$34.79M$32.22M$31.92M$28.80M$28.43M$28.21M
Operating income$6.96M$4.46M$4.30M$8.37M$5.64M$5.09M$3.84M$6.45M
Interest expense$177,000$248,000$305,000—$507,000$132,000$179,000—
Pretax income$6.79M$4.05M$3.99M$8.01M$5.13M$4.96M$3.66M$6.30M
Income tax$2.05M$1.15M$1.28M$2.19M$1.53M$1.71M$952,000$1.88M
Net income$4.64M$2.76M$2.58M$5.64M$3.51M$3.16M$2.62M$4.32M
EBITDA$7.35M$4.85M$11.92M$15.94M$6.04M$5.45M$10.45M$12.82M
EPS (basic)0.120.070.07—0.090.080.07—
EPS (diluted)0.110.070.06—0.090.080.06—
Weighted avg. shares (diluted)41.19M41.13M40.49M—40.50M41.08M41.63M—
Balance sheet
Cash & equivalents$9.68M$10.68M$9.76M$13.50M$11.12M$20.02M$10.16M$17.54M
Receivables$34.89M$32.23M$31.18M$25.59M$27.41M$26.55M$26.79M$24.91M
Inventory$4.55M$5.27M$5.18M$5.05M$5.27M$4.32M$4.51M$4.32M
Current assets$59.29M$53.97M$49.81M$48.49M$49.98M$55.29M$49.12M$52.88M
PP&E, net$75.60M$77.16M$76.01M$78.78M$80.51M$79.73M$81.05M$76.28M
Goodwill$58.94M$58.94M$58.94M$58.94M$58.46M$32.99M$32.99M$32.99M
Intangibles$1.09M$1.16M$1.22M$1.28M$1.35M$783,000$816,000$848,000
Total assets$207.63M$204.22M$197.36M$199.15M$202.36M$184.60M$178.08M$177.07M
Current liabilities$47.32M$47.89M$40.71M$41.06M$44.19M$37.27M$35.49M$37.33M
Short-term debt$511,000$717,000$871,000$1.09M$1.55M$820,000$390,000$409,000
Long-term debt$4.51M$6.37M$8.33M$11.29M$19.59M$3.46M$3.53M$3.59M
Total debt$5.02M$7.09M$9.21M$12.38M$21.14M$4.29M$3.92M$4.00M
Total liabilities$55.65M$58.26M$51.56M$55.63M$66.86M$42.98M$41.33M$43.77M
Shareholders' equity$150.09M$144.03M$143.86M$141.54M$133.61M$139.73M$134.76M$131.39M
Net debt-$4.66M-$3.59M-$557,000-$1.12M$10.02M-$15.73M-$6.24M-$13.54M
Shares outstanding38.05M38.09M38.53M38.02M38.02M39.61M39.52M39.13M
Cash flow statement
Operating cash flow$11.49M$15.90M$8.07M$18.44M$18.37M$12.25M$2.85M$14.99M
Capital expenditure$8.62M$8.46M$6.71M$8.74M$7.64M$8.13M$15.48M$11.83M
Free cash flow$2.87M$7.44M$1.36M$9.70M$10.73M$4.12M-$12.63M$3.16M
Investing cash flow-$7.46M-$7.84M-$5.49M-$7.61M-$32.30M-$1.73M-$8.53M-$9.20M
Financing cash flow-$5.03M-$7.15M-$6.33M-$8.45M$5.04M-$671,000-$1.70M$404,000
Depreciation & amortization$392,000$388,000$7.62M$7.57M$397,000$353,000$6.61M$6.37M
Stock-based compensation$2.48M$2.03M$2.45M$2.30M$2.18M$2.34M$2.31M$1.52M
Share buybacks$977,000$5.32M$1.44M$0$11.56M$1.66M$0$0

Free plan shows the latest 8 periods; Pro shows all 35 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.